Global cancer transitions according to the Human Development Index (2008-2030): a population-based study.

[1]  A. Omran.  The epidemiologic transition. A theory of the epidemiology of population change. , 1971, The Milbank Memorial Fund quarterly.

[2]  D. Hunter,et al.  Textbook of cancer epidemiology , 2003 .

[3]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[4]  Martin McKee,et al.  UN High-Level Meeting on Non-Communicable Diseases: addressing four questions , 2011, The Lancet.

[5]  V. Patel,et al.  Suicide mortality in India: a nationally representative survey , 2012, The Lancet.

[6]  Francesco C. Billari,et al.  Advances in development reverse fertility declines , 2009, Nature.

[7]  J. Church.  Human Development Report , 2001 .

[8]  D. Parkin,et al.  Changing cancer incidence in Kampala, Uganda, 1991–2006 , 2010, International journal of cancer.

[9]  D. Yach,et al.  The global burden of chronic diseases: overcoming impediments to prevention and control. , 2004, JAMA.

[10]  G. Davey Smith,et al.  Non‐communicable diseases in low‐ and middle‐income countries: context, determinants and health policy , 2008, Tropical medicine & international health : TM & IH.

[11]  R. Sankaranarayanan,et al.  Verbal-autopsy-based projection of cancer deaths in India , 2012, The Lancet.

[12]  F. Bray,et al.  Cancer burden in the year 2000. The global picture. , 2001, European journal of cancer.

[13]  Richard Doll,et al.  Cancer incidence in five continents : a technical report , 1966 .

[14]  E. Wynder,et al.  The decline in gastric cancer: epidemiology of an unplanned triumph. , 1986, Epidemiologic reviews.

[15]  K. Morris.  UN raises priority of non-communicable diseases , 2010, The Lancet.

[16]  E. Giovannucci,et al.  Primary prevention of colorectal cancer. , 2010, Gastroenterology.

[17]  C. Mathers,et al.  Chronic Diseases: Chronic Diseases and Development 5 Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries , 2010 .

[18]  M. Planck.  The Cancer Transition in Japan since 1951 , 2002 .

[19]  J. Ferlay,et al.  Breast and cervical cancer in 187 countries between 1980 and 2010 , 2012, The Lancet.

[20]  J. Klugman.  Human Development Report 2009. Overcoming Barriers: Human Mobility and Development , 2009 .

[21]  Prabhat Jha,et al.  Avoidable global cancer deaths and total deaths from smoking , 2009, Nature Reviews Cancer.

[22]  Jeffrey D Sachs,et al.  Expansion of cancer care and control in countries of low and middle income: a call to action , 2010, The Lancet.

[23]  F. Bray,et al.  Cancer mortality in India: a nationally representative survey , 2012, The Lancet.

[24]  T. Lancet.  GAVI's challenges: funding and leadership , 2010, The Lancet.

[25]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[26]  I. February.  The World Cancer Declaration: is the world catching up? , 2010 .

[27]  T. Guthrie,et al.  Prostate cancer. , 2020, American family physician.

[28]  R. Peek,et al.  Helicobacter pylori: gastric cancer and beyond , 2010, Nature Reviews Cancer.

[29]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[30]  A. Alwan.  Global status report on noncommunicable diseases 2010. , 2011 .

[31]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[32]  J. Gerberding,et al.  Progress in hepatitis B prevention through universal infant vaccination--China, 1997-2006. , 2007, MMWR. Morbidity and mortality weekly report.

[33]  R. Doll,et al.  The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. , 1981, Journal of the National Cancer Institute.

[34]  Alan D. Lopez,et al.  Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis , 2011, The Lancet.

[35]  Chien-Jen Chen,et al.  Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. , 2009, Journal of the National Cancer Institute.

[36]  A. Ezzat,et al.  Book review: National cancer control programmes, policies and managerial guidelines. , 1996, Annals of Saudi medicine.

[37]  F. Bray,et al.  Predicting the future burden of cancer , 2006, Nature Reviews Cancer.

[38]  B. Bell,et al.  The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. , 2006, Journal of hepatology.

[39]  P. Gluckman,et al.  Priority actions for the non-communicable disease crisis , 2011, The Lancet.

[40]  C. Wild,et al.  A million africans a year dying from cancer by 2030: What can cancer research and control offer to the continent? , 2012, International journal of cancer.